Can L. Tian
No. 283, Tongzipo Road
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Dual-Physical-Field Nanocatalysis: Injectable Hydrogel Enables Piezo-Photothermal Synergy for Breast Cancer Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 09, 2025
Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: June 28, 2025
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label study.
Journal: Breast (Edinburgh, Scotland)
Published: March 19, 2025
Pyrotinib versus pertuzumab with trastuzumab and taxane in HER2-positive metastatic breast cancer: a Chinese multicenter real-world study.
Journal: The oncologist
Published: February 22, 2025
Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancer.
Journal: Cancer innovation
Published: April 11, 2024
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody.
Journal: Breast (Edinburgh, Scotland)
Published: September 21, 2023
The treatment pattern of advanced HR-positive and HER2-negative breast cancer in central southern China: a hospital-based cross-sectional study.
Journal: BMC cancer
Published: September 20, 2023
A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer.
Journal: ESMO open
Published: March 21, 2023
Artificial intelligence scale-invariant feature transform algorithm-based system to improve the calculation accuracy of Ki-67 index in invasive breast cancer: a multicenter retrospective study.
Journal: Annals of translational medicine
Published: August 16, 2022
The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA.
Journal: Breast (Edinburgh, Scotland)
Published: June 13, 2022
The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study.
Journal: Annals of translational medicine
Published: March 02, 2022
Last Updated: 09/26/2026